Abstract
Background and Objective Mendelian randomization (MR) has become an important tool in epidemiology, used to infer causal relationships diseases. This review aims to consolidate existing MR evidence concerning celiac disease (CeD).
Methods We systematically searched major databases up to May 2024, adhering to PRISMA guidelines. Only MR studies explicitly investigating CeD were included. We assessed the quality of each study based on the strength, independence, and exclusivity of the instrumental variables used.
Results From an initial pool of 207 articles, 35 met our inclusion criteria. These studies frequently addressed the relationship between CeD and autoimmune diseases like inflammatory bowel disease (IBD) and explored connections with gut microbiota, various cancers, and metabolic disorders. Significant findings highlight a robust bi-directional association between IBD and CeD and complex interactions with gut microbiota. Notably, many associations reported were near the threshold of clinical significance.
Conclusion This systematic review highlights the dual nature of current MR evidence on CeD. On one hand, we observe consistent associations between CeD, IBDs, and gut microbiota. On the other, there is a plethora of weaker associations that raise critical questions about their clinical and research significance. This work lays a solid foundation for deeper investigations into these weaker links, particularly in relation to lymphomas and psychiatric conditions. It calls for an expanded use of MR and other methodologies to explore under-researched areas.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
One author was added to the authors list as she was mistakenly left out through the initial submission, although she had a substantial role in writing and editing the manuscript
Data Availability
All data produced in the present study are available upon reasonable request to the authors
